US Stock MarketDetailed Quotes

KNSA Kiniksa Pharmaceuticals International

Watchlist
  • 21.280
  • +0.190+0.90%
Close Nov 22 16:00 ET
  • 21.400
  • +0.120+0.56%
Post 17:59 ET
1.54BMarket Cap-177333P/E (TTM)

Kiniksa Pharmaceuticals International Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-113.16%-2.24M
238.07%5.17M
193.44%3.99M
129.05%13.3M
137.36%4.33M
-72.63%16.99M
52.16%-3.74M
88.42%-4.27M
104.60%5.81M
38.70%-11.58M
Net income from continuing operations
8.39%-12.69M
-126.10%-3.91M
-44.29%-17.7M
-92.32%14.08M
465.73%25.24M
-106.18%-13.86M
174.93%14.97M
51.33%-12.27M
216.11%183.36M
112.28%4.46M
Operating gains losses
--0
----
----
442.42%179K
-60.00%4K
--0
--0
--175K
-67.96%33K
--10K
Depreciation and amortization
-33.83%399K
-28.57%430K
-21.81%466K
-2.54%2.34M
-10.30%540K
22.31%603K
-7.53%602K
-9.15%596K
2.00%2.4M
-9.88%602K
Deferred tax
-135.37%-3.64M
154.36%10.57M
305.29%4.37M
81.78%-33.79M
-7,487.64%-25.71M
105.54%10.29M
---19.44M
--1.08M
-1,686,418.18%-185.5M
3,063.64%348K
Other non cash items
6.65%754K
8.71%836K
-7.37%779K
0.43%3.05M
-6.47%737K
-8.42%707K
3.08%769K
14.42%841K
15.58%3.04M
7.07%788K
Change In working capital
-49.12%5.6M
-66.19%-9.91M
3,199.23%8.58M
105.98%1.35M
83.46%-3.96M
-33.76%11.01M
-250.05%-5.96M
101.35%260K
-3,376.49%-22.58M
-345.61%-23.95M
-Change in receivables
-120.53%-4.44M
74.13%-4.46M
-59.11%5.27M
94.18%-950K
-99.03%-18.23M
744.85%21.61M
-179.63%-17.23M
150.65%12.89M
-317.67%-16.33M
-1,234.84%-9.16M
-Change in inventory
480.18%6.18M
-1,322.14%-7.58M
310.51%3.84M
46.87%-9.52M
20.62%-5.54M
-130.69%-1.63M
92.04%-533K
80.88%-1.83M
-387.73%-17.92M
-461.37%-6.98M
-Change in prepaid assets
50.01%-6.99M
-1,971.23%-13.27M
242.37%3.75M
-83.18%-7.07M
81.70%8.85M
-971.80%-13.99M
120.32%709K
33.01%-2.63M
-231.18%-3.86M
155.27%4.87M
-Change in payables and accrued expense
46.85%11.71M
46.12%20.38M
103.63%623K
644.49%17.29M
374.42%12.52M
768.41%7.97M
304.10%13.95M
-406.34%-17.16M
-80.16%2.32M
-74.36%2.64M
-Change in other current assets
---10K
-4,165.56%-3.84M
-202.88%-3.36M
72.72%4.58M
630.57%1.41M
--0
-155.21%-90K
18.62%3.27M
180.82%2.65M
88.09%-265K
-Change in other current liabilities
-18.28%-841K
-25.41%-997K
-32.98%-1.25M
-125.45%-3.24M
-2.85%-793K
-191.27%-711K
1.12%-795K
-46.88%-943K
53.43%-1.44M
47.48%-771K
-Change in other working capital
99.96%-1K
92.16%-155K
-104.42%-294K
-97.83%261K
84.78%-2.18M
-115.70%-2.24M
---1.98M
-44.52%6.66M
--12M
---14.29M
Cash from discontinued investing activities
Operating cash flow
-113.16%-2.24M
238.07%5.17M
193.44%3.99M
129.05%13.3M
137.36%4.33M
-72.63%16.99M
52.16%-3.74M
88.42%-4.27M
104.60%5.81M
38.70%-11.58M
Investing cash flow
Cash flow from continuing investing activities
48.29%-6.35M
-231.70%-46.8M
167.31%25.52M
-265.90%-29.56M
65.09%-14.89M
-164.48%-12.28M
-7.14%35.53M
-66.88%-37.92M
-106.28%-8.08M
14.75%-42.66M
Net PPE purchase and sale
--0
173.53%25K
-250.00%-84K
-828.57%-130K
-233.33%-56K
50.00%-16K
-41.67%-34K
---24K
96.63%-14K
116.73%42K
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
--0
----
Net investment purchase and sale
48.23%-6.35M
-231.64%-46.82M
167.57%25.61M
-264.92%-29.43M
65.25%-14.84M
-164.29%-12.26M
-7.11%35.57M
-66.77%-37.9M
-105.41%-8.06M
14.24%-42.7M
Cash from discontinued investing activities
Investing cash flow
48.29%-6.35M
-231.70%-46.8M
167.31%25.52M
-265.90%-29.56M
65.09%-14.89M
-164.48%-12.28M
-7.14%35.53M
-66.88%-37.92M
-106.28%-8.08M
14.75%-42.66M
Financing cash flow
Cash flow from continuing financing activities
1,111.78%6.69M
-212.66%-178K
3,914.44%3.61M
-40.58%1.5M
-41.60%695K
52.91%552K
-70.85%158K
-78.72%90K
-57.25%2.52M
-1.82%1.19M
Net common stock issuance
-145.43%-2.71M
-213.37%-1.31M
9.29%-381K
-144.84%-2.21M
-162.00%-262K
-431.25%-1.11M
-1,645.83%-419K
26.19%-420K
---901K
97.86%-100K
Proceeds from stock option exercised by employees
467.35%9.4M
96.71%1.14M
683.14%3.99M
8.31%3.7M
-25.81%957K
191.21%1.66M
1.94%577K
-48.59%510K
-41.94%3.42M
--1.29M
Cash from discontinued financing activities
Financing cash flow
1,111.78%6.69M
-212.66%-178K
3,914.44%3.61M
-40.58%1.5M
-41.60%695K
52.91%552K
-70.85%158K
-78.72%90K
-57.25%2.52M
-1.82%1.19M
Net cash flow
Beginning cash position
-11.81%99.27M
75.00%141.08M
-12.03%107.95M
0.20%122.72M
-32.96%117.83M
19.36%112.57M
27.31%80.62M
0.20%122.72M
7.20%122.47M
-7.58%175.76M
Current changes in cash
-136.02%-1.9M
-230.86%-41.81M
178.68%33.12M
-6,124.90%-14.76M
81.39%-9.87M
-93.54%5.26M
3.12%31.95M
28.83%-42.1M
-97.02%245K
21.66%-53.05M
End cash Position
-17.36%97.38M
-11.81%99.27M
75.00%141.08M
-12.03%107.95M
-12.03%107.95M
-32.96%117.83M
19.36%112.57M
27.31%80.62M
0.20%122.72M
0.20%122.72M
Free cash flow
-113.18%-2.24M
236.83%5.17M
190.96%3.9M
130.99%13.17M
136.98%4.27M
-72.64%16.97M
52.42%-3.78M
88.35%-4.29M
103.89%5.7M
39.67%-11.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -113.16%-2.24M238.07%5.17M193.44%3.99M129.05%13.3M137.36%4.33M-72.63%16.99M52.16%-3.74M88.42%-4.27M104.60%5.81M38.70%-11.58M
Net income from continuing operations 8.39%-12.69M-126.10%-3.91M-44.29%-17.7M-92.32%14.08M465.73%25.24M-106.18%-13.86M174.93%14.97M51.33%-12.27M216.11%183.36M112.28%4.46M
Operating gains losses --0--------442.42%179K-60.00%4K--0--0--175K-67.96%33K--10K
Depreciation and amortization -33.83%399K-28.57%430K-21.81%466K-2.54%2.34M-10.30%540K22.31%603K-7.53%602K-9.15%596K2.00%2.4M-9.88%602K
Deferred tax -135.37%-3.64M154.36%10.57M305.29%4.37M81.78%-33.79M-7,487.64%-25.71M105.54%10.29M---19.44M--1.08M-1,686,418.18%-185.5M3,063.64%348K
Other non cash items 6.65%754K8.71%836K-7.37%779K0.43%3.05M-6.47%737K-8.42%707K3.08%769K14.42%841K15.58%3.04M7.07%788K
Change In working capital -49.12%5.6M-66.19%-9.91M3,199.23%8.58M105.98%1.35M83.46%-3.96M-33.76%11.01M-250.05%-5.96M101.35%260K-3,376.49%-22.58M-345.61%-23.95M
-Change in receivables -120.53%-4.44M74.13%-4.46M-59.11%5.27M94.18%-950K-99.03%-18.23M744.85%21.61M-179.63%-17.23M150.65%12.89M-317.67%-16.33M-1,234.84%-9.16M
-Change in inventory 480.18%6.18M-1,322.14%-7.58M310.51%3.84M46.87%-9.52M20.62%-5.54M-130.69%-1.63M92.04%-533K80.88%-1.83M-387.73%-17.92M-461.37%-6.98M
-Change in prepaid assets 50.01%-6.99M-1,971.23%-13.27M242.37%3.75M-83.18%-7.07M81.70%8.85M-971.80%-13.99M120.32%709K33.01%-2.63M-231.18%-3.86M155.27%4.87M
-Change in payables and accrued expense 46.85%11.71M46.12%20.38M103.63%623K644.49%17.29M374.42%12.52M768.41%7.97M304.10%13.95M-406.34%-17.16M-80.16%2.32M-74.36%2.64M
-Change in other current assets ---10K-4,165.56%-3.84M-202.88%-3.36M72.72%4.58M630.57%1.41M--0-155.21%-90K18.62%3.27M180.82%2.65M88.09%-265K
-Change in other current liabilities -18.28%-841K-25.41%-997K-32.98%-1.25M-125.45%-3.24M-2.85%-793K-191.27%-711K1.12%-795K-46.88%-943K53.43%-1.44M47.48%-771K
-Change in other working capital 99.96%-1K92.16%-155K-104.42%-294K-97.83%261K84.78%-2.18M-115.70%-2.24M---1.98M-44.52%6.66M--12M---14.29M
Cash from discontinued investing activities
Operating cash flow -113.16%-2.24M238.07%5.17M193.44%3.99M129.05%13.3M137.36%4.33M-72.63%16.99M52.16%-3.74M88.42%-4.27M104.60%5.81M38.70%-11.58M
Investing cash flow
Cash flow from continuing investing activities 48.29%-6.35M-231.70%-46.8M167.31%25.52M-265.90%-29.56M65.09%-14.89M-164.48%-12.28M-7.14%35.53M-66.88%-37.92M-106.28%-8.08M14.75%-42.66M
Net PPE purchase and sale --0173.53%25K-250.00%-84K-828.57%-130K-233.33%-56K50.00%-16K-41.67%-34K---24K96.63%-14K116.73%42K
Net intangibles purchase and sale --------------0------------------0----
Net investment purchase and sale 48.23%-6.35M-231.64%-46.82M167.57%25.61M-264.92%-29.43M65.25%-14.84M-164.29%-12.26M-7.11%35.57M-66.77%-37.9M-105.41%-8.06M14.24%-42.7M
Cash from discontinued investing activities
Investing cash flow 48.29%-6.35M-231.70%-46.8M167.31%25.52M-265.90%-29.56M65.09%-14.89M-164.48%-12.28M-7.14%35.53M-66.88%-37.92M-106.28%-8.08M14.75%-42.66M
Financing cash flow
Cash flow from continuing financing activities 1,111.78%6.69M-212.66%-178K3,914.44%3.61M-40.58%1.5M-41.60%695K52.91%552K-70.85%158K-78.72%90K-57.25%2.52M-1.82%1.19M
Net common stock issuance -145.43%-2.71M-213.37%-1.31M9.29%-381K-144.84%-2.21M-162.00%-262K-431.25%-1.11M-1,645.83%-419K26.19%-420K---901K97.86%-100K
Proceeds from stock option exercised by employees 467.35%9.4M96.71%1.14M683.14%3.99M8.31%3.7M-25.81%957K191.21%1.66M1.94%577K-48.59%510K-41.94%3.42M--1.29M
Cash from discontinued financing activities
Financing cash flow 1,111.78%6.69M-212.66%-178K3,914.44%3.61M-40.58%1.5M-41.60%695K52.91%552K-70.85%158K-78.72%90K-57.25%2.52M-1.82%1.19M
Net cash flow
Beginning cash position -11.81%99.27M75.00%141.08M-12.03%107.95M0.20%122.72M-32.96%117.83M19.36%112.57M27.31%80.62M0.20%122.72M7.20%122.47M-7.58%175.76M
Current changes in cash -136.02%-1.9M-230.86%-41.81M178.68%33.12M-6,124.90%-14.76M81.39%-9.87M-93.54%5.26M3.12%31.95M28.83%-42.1M-97.02%245K21.66%-53.05M
End cash Position -17.36%97.38M-11.81%99.27M75.00%141.08M-12.03%107.95M-12.03%107.95M-32.96%117.83M19.36%112.57M27.31%80.62M0.20%122.72M0.20%122.72M
Free cash flow -113.18%-2.24M236.83%5.17M190.96%3.9M130.99%13.17M136.98%4.27M-72.64%16.97M52.42%-3.78M88.35%-4.29M103.89%5.7M39.67%-11.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data